SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-04-018787
Filing Date
2004-07-02
Accepted
2004-07-01 17:50:41
Documents
7
Period of Report
2004-06-24
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a04-7156_28k.htm 8-K 25909
2 EX-99.1 a04-7156_2ex99d1.htm EX-99.1 14797
3 EX-99.2 a04-7156_2ex99d2.htm EX-99.2 376016
4 EX-99.3 a04-7156_2ex99d3.htm EX-99.3 24475
5 EX-99.4 a04-7156_2ex99d4.htm EX-99.4 441320
6 GRAPHIC g71562moimage002.jpg GRAPHIC 7306
7 GRAPHIC g71562moimage004.jpg GRAPHIC 2834
  Complete submission text file 0001104659-04-018787.txt   894808
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 04896385
SIC: 2834 Pharmaceutical Preparations